These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12376805)

  • 1. Elevated bone turnover in rat polycystic kidney disease is not due to prostaglandin E2.
    Weiler H; Kovacs H; Nitschmann E; Fitzpatrick Wong S; Bankovic-Calic N; Ogborn M
    Pediatr Nephrol; 2002 Oct; 17(10):795-9. PubMed ID: 12376805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease.
    Ogborn MR; Nitschmann E; Bankovic-Calic N; Weiler HA; Fitzpatrick-Wong S; Aukema HM
    Kidney Int; 2003 Oct; 64(4):1214-21. PubMed ID: 12969139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of dietary n-3 long-chain polyunsaturated fatty acids on femur mineral density and biomarkers of bone metabolism in healthy, diabetic and dietary-restricted growing rats.
    Green KH; Wong SC; Weiler HA
    Prostaglandins Leukot Essent Fatty Acids; 2004 Aug; 71(2):121-30. PubMed ID: 15207529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feeding flaxseed oil but not secoisolariciresinol diglucoside results in higher bone mass in healthy rats and rats with kidney disease.
    Weiler HA; Kovacs H; Nitschmann E; Bankovic-Calic N; Aukema H; Ogborn M
    Prostaglandins Leukot Essent Fatty Acids; 2007 May; 76(5):269-75. PubMed ID: 17403603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of bone quality in gonad-intact middle-aged male rats by long-chain n-3 polyunsaturated fatty acid.
    Shen CL; Yeh JK; Rasty J; Chyu MC; Dunn DM; Li Y; Watkins BA
    Calcif Tissue Int; 2007 Apr; 80(4):286-93. PubMed ID: 17406770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomized rats.
    Watkins BA; Li Y; Seifert MF
    J Nutr Biochem; 2006 Apr; 17(4):282-9. PubMed ID: 16102959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feeding soy protein isolate and oils rich in omega-3 polyunsaturated fatty acids affected mineral balance, but not bone in a rat model of autosomal recessive polycystic kidney disease.
    Maditz KH; Smith BJ; Miller M; Oldaker C; Tou JC
    BMC Nephrol; 2015 Feb; 16():13. PubMed ID: 25886405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary n-3 polyunsaturated fatty acids or soy protein isolate did not attenuate disease progression in a female rat model of autosomal recessive polycystic kidney disease.
    Maditz KH; Oldaker C; Nanda N; Benedito V; Livengood R; Tou JC
    Nutr Res; 2014 Jun; 34(6):526-34. PubMed ID: 25026920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats.
    Aukema HM; Housini I
    Kidney Int; 2001 Jan; 59(1):52-61. PubMed ID: 11135057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary soy protein selectively reduces renal prostanoids and cyclooxygenases in polycystic kidney disease.
    Peng CY; Sankaran D; Ogborn MR; Aukema HM
    Exp Biol Med (Maywood); 2009 Jul; 234(7):737-43. PubMed ID: 19429858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of renal failure in the Han: SPRD polycystic kidney rat.
    Zeier M; Pohlmeyer G; Deerberg F; Schönherr R; Ritz E
    Nephrol Dial Transplant; 1994; 9(12):1734-9. PubMed ID: 7708256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of renal injury in pcy mice by dietary fat containing n-3 fatty acids depends on the level and type of fat.
    Sankaran D; Lu J; Bankovic-Calic N; Ogborn MR; Aukema HM
    Lipids; 2004 Mar; 39(3):207-14. PubMed ID: 15233398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugated linoleic acid reduces parathyroid hormone in health and in polycystic kidney disease in rats.
    Weiler H; Austin S; Fitzpatrick-Wong S; Nitschmann E; Bankovic-Calic N; Mollard R; Aukema H; Ogborn M
    Am J Clin Nutr; 2004 Jun; 79(6 Suppl):1186S-1189S. PubMed ID: 15159255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender.
    Ogborn MR; Nitschmann E; Bankovic-Calic N; Weiler HA; Aukema HM
    Lipids; 2006 Dec; 41(12):1141-9. PubMed ID: 17269560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone.
    Iwasaki-Ishizuka Y; Yamato H; Nii-Kono T; Kurokawa K; Fukagawa M
    Nephrol Dial Transplant; 2005 Sep; 20(9):1904-11. PubMed ID: 15985520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidism.
    Padagas J; Colloton M; Shalhoub V; Kostenuik P; Morony S; Munyakazi L; Guo M; Gianneschi D; Shatzen E; Geng Z; Tan HL; Dunstan C; Lacey D; Martin D
    Calcif Tissue Int; 2006 Jan; 78(1):35-44. PubMed ID: 16362459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.